NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-217-1998-0-GB-12 Virus-Like Particles for the Induction of Autoantibodies GB EP 99970772.2 Abandoned
NCI E-217-1998-0-AU-03 Virus-Like Particles for the Induction of Autoantibodies AU National Stage 12143/00 Expired
NCI E-217-1998-0-PCT-02 Chimeric Virus-Like Particles for the Induction of Autoantibodies PCT PCT PCT/US1999/024548 Expired
NCI E-217-1998-0-EP-10 Virus-Like Particles for the Induction of Autoantibodies EP DIV 05027951.2 Abandoned
NCI E-012-1993-0-US-05 METHOD FOR TREATING TAXOL SIDE-EFFECTS WITH G-CSF US CON 09/420,082 38424 Expired PDF
NCI E-301-1998-2-AU-03 Combination Therapy With VIP Antagonist AU National Stage 12097/00 Abandoned
NCI E-301-1998-2-PCT-01 Combination Therapy With VIP Antagonist PCT PCT COMB PCT/US1999/024268 Expired
NCI E-301-1998-2-EP-02 Combination Therapy With VIP Antagonist EP National Stage 99970603.9 Abandoned
NCI E-301-1998-2-JP-05 Combination Therapy With VIP Antagonist JP National Stage 2000-576869 Abandoned
NINDS E-132-1996-0-US-03 IMMUNOTOXIN (MAB-RICIN) FOR THE TREATMENT OF FOCAL MOVEMENT DISORDERS US CON 09/418,854 Abandoned
NCI E-301-1998-2-CA-04 Comb ination Therapy With VIP Antagonist CA National Stage 2346866 Abandoned
NCI E-030-1999-0-CA-04 Novel Indenoisoquinoline As Antineloplastic Agents CA National Stage 2347100 Abandoned
NCI E-030-1999-0-JP-06 Novel Indenoisoquinoline as Antineoplastic Agent JP National Stage 575513/2000 Expired
NCI E-030-1999-0-EP-05 Novel Indenoisoquinolines As Antineoplastic Agents EP National Stage 99970323.4 Expired
NCI E-030-1999-0-GB-11 Novel Indenoisoquinolines As Antineoplastic Agents GB EP 99970323.4 Expired
NCI E-030-1999-0-DE-09 Novel Indenoisoquinolines As Antineoplastic Agents DE EP 99970323.4 Expired
NCI E-030-1999-0-FR-10 Novel Indenoisoquinolines As Antineoplastic Agents FR EP 99970323.4 Expired
NCI E-030-1999-0-AU-03 Novel Indenoisoquinoline As Antineoplastic Agents AU National Stage 12043/00 Expired
NCI E-030-1999-0-PCT-02 NOVEL INDENOISOQUINOLINES AS ANTINEOPLASTIC AGENTS PCT PCT PCT/US1999/023900 Expired
NCI E-030-1999-0-EP-08 Novel Indenoisoquinolines As Antineoplastic Agents EP DIV 09000858.2 Expired
NCI E-257-1999-0-US-01 CC-CHEMOKINE RECEPTOR 5(CCR5) GENE IS ASSOCIATED WITH AN INCREASED RISK OF HYPERTENSION US 60/159,688 Abandoned
NHLBI E-241-1998-0-AU-03 Electroacoustic Imaging Methods and Apparatus AU National Stage 63931/99 Abandoned
NCI E-074-1999-1-US-01 Cyanovirin Conjugates and Matrix-Anchored Cyanovirin and Related Compositions and Methods of Use US CIP 09/416,434 6428790 Expired PDF
NHLBI E-241-1998-0-PCT-02 Electroacoustic Imaging Methods and Apparatus PCT PCT PCT/US1999/021610 Expired
NHLBI E-241-1998-0-EP-05 Electroacoustic Imaging Methods and Apparatus EP National Stage 99951500.0 Abandoned
NHGRI E-198-1999-0-US-01 Identification and Cloning of the Gene Responsible for Hereditary Prostate Cancer (cased refiled under E-196-01/0) US 60/159,136 Abandoned
NHLBI E-241-1998-0-CA-04 Electroacoustic Imaging Methods and Apparatus CA National Stage 2347216 Abandoned
NIMH E-011-1999-2-US-01 DIRECT USE OF TISSUE TO ISOLATE ANTI-HDS MODIFIED PHAGE US 60/158,375 Abandoned
NCI E-071-1992-1-US-03 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA US CON 09/414,117 6291664 Expired PDF
NIAID E-200-1993-0-US-03 OLIGOMERIC HIV-1 ENVELOPE GLYCOPROTEINS US DIV 09/415,326 Abandoned
NCI E-226-1993-0-AU-04 TREATMENT OF CANCER WITH HUMAN CHORIONIC GONADOTROPIN AU DIV 53516/99 Abandoned
NCI E-002-1999-1-US-02 Method of Reversing Chemotherapeutic Drug Resistance in Tumor or Cancer Cells Utitlizing an Acidically-Modified Dominant Negative US ORD 09/414,089 Abandoned
NCI E-090-2001-0-US-01 Retroviral Protease Inhibiting Compound and Methods of Preparation, Pharmaceutical Compositions and Methods of Treating Viral Infections US 60/157,850 Abandoned
NIMH E-281-1999-0-US-01 Tyrosine-DNA Phosphodiestrerases(TDP) and Related Polypeptides, Nucleic Acids, Vectors, TDP-Producing Host Cells, Antibodies... US 60/157,690 Abandoned
NCI E-143-1996-0-US-03 NOVEL LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY US National Stage 09/242,190 6413544 Expired PDF
NCI E-257-2008-0-US-08 Melanoma Associated Peptide Analogues And Vaccines Against Melanoma US National Stage 09/214,836 Abandoned
NCI E-243-1999-0-US-01 FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN FOR HUMAN RENAL CELL CANCER US 60/157,103 Abandoned
NCI E-104-1999-1-US-01 T-Cell Receptor Gamma Transcript in Prostate Epithelial Cells US 60/157,471 Abandoned
NIA E-284-1998-0-PCT-02 A Method of Using a Beta2-Adrenergic Receptor Agonist That Selectively Activates GS Proteins in the Treatment of Cardiovascular Disease PCT PCT PCT/US1999/022712 Expired
NHLBI E-093-1998-0-PCT-02 Ultrasound Array and Electrode Array for Hall Effect Imaging PCT PCT PCT/US99/022792 Abandoned
NHLBI E-243-1998-0-PCT-02 Ultrasound Probes Implementing Waveguide Shielding and Active Compensation of Noise PCT PCT PCT/US99/022544 Abandoned
NCI E-299-1999-0-US-01 Cloning and Characterization of ILP2 and ILP3 US 60/157,169 Abandoned
NCI E-120-2000-0-US-01 Chromosome Alterations In Prostate Cancer US 60/156,957 Abandoned
NHGRI E-212-1998-0-US-02 Ratio-Based Decisions and The Quantitative Analysis of cDNA Micro- Array Images US ORD 09/407,021 6245517 Expired PDF
NIDDK E-189-2001-0-US-01 USE OF PENTAGASTRIN TO INHIBIT GASTRIC ACID SECRETION OR AS A DIURETIC US 60/156,491 Abandoned
NIAID E-099-1997-0-US-02 RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES US DIV 09/407,033 Abandoned
NIDCR E-227-1998-0-PCT-02 Osteonectin related protein responsible for cancer cell metastasis to bone PCT PCT PCT/US__/____ Expired
NCI E-025-1999-0-US-01 Interleukin-2 Receptor Associated Polypeptides US 60/155,968 Abandoned
NIAID E-293-1999-0-US-01 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metallo... US 60/155,961 Abandoned
NIDCR E-044-1998-0-PCT-02 Methods of Treating Chronic Pain PCT PCT PCT/US1999/022103 Expired